LATEST NEWS
Special notice: For important updates about COVID-19 and its impact on CNSI facilities, please visit our Coronavirus guidance page.
July 26, 2020 | A team of UCLA researchers receives state grant for potential COVID-19 drug treatment
A team of UCLA researchers received a state grant to test a new drug as a potential treatment for COVID-19.A team of UCLA researchers receives state grant for potential COVID-19 drug treatment By Priscilla GuerreroThis article was originally published by the Daily...
July 16, 2020 | Paul Weiss Elected Honorary Fellow of CRSI
Professor Paul Weiss has been elected as Honorary Fellow of the Chemical Research Society of India (CRSI) for the year 2020-21.July 16, 2020 | Paul Weiss Elected Honorary Fellow of CRSI By Penny Jennings This article was originally published by UCLA Chemistry...
July 9, 2020 | Researchers receive Department of Energy grant to transform carbon dioxide into construction materials
The technology for producing CO2Concrete is being demonstrated at the Wyoming Integrated Test Center at the Dry Fork Station in Gillette, Wyoming.July 9, 2020 | Researchers receive Department of Energy grant to transform carbon dioxide into construction materials by...
July 3, 2020 | How the body regulates scar tissue growth after heart attacks
New UCLA research conducted in mice could explain why some people suffer more extensive scarring than others after a heart attack. The study, published in the journal Cell, reveals that a protein known as type 5 collagen plays a critical role in regulating the size of...
June 29, 2020 | Pharma’s Dirty Secret, And The Synthetic Biology Startup Offering A New Approach
Octant Bio, the Bay Area, CA-based synthetic biology startup and graduate of Magnify Incubator) is using an approach to multi-receptor drugs that you may never have heard of, but that you definitely haven’t heard the last of.July 2, 2020 | Pharma’s Dirty Secret, And...
June 29, 2020 | High schoolers learn science and business through Nanovation Competition
The winning entries in UCLA’s fourth annual Nanovation Competition may not represent actual products — yet — but the science behind them is very real. That’s one of the core requirements of the contest, which invites Southern California middle and high school students...
June 22, 2020 | New technique allows scientists to measure mitochondrial respiration in frozen tissue
Scientists led by Dr. Orian Shirihai, director of the metabolism theme at the David Geffen School of Medicine at UCLA, have developed a method for restoring oxygen-consumption activity to previously frozen mitochondria samples, even years after they have been...
June 17, 2020 | Adhesive film turns smartwatch into biochemical health monitoring system
UCLA engineers have designed a thin adhesive film that could upgrade a consumer smartwatch into a powerful health monitoring system. The system looks for chemical indicators found in sweat to give a real-time snapshot of what’s happening inside the body.June 17, 2020...
June 1, 2020 | Coronavirus vaccine development underway by Vault Pharma
An emerging company developing biotechnology invented at UCLA is adapting their approach to address the novel coronavirus, with the goal of adding to the anti-COVID-19 arsenal that follows an initial vaccine. The company, Vault Pharma, is working with UCLA and other...
May 29, 2020 | Large Droplet-Sorting Now Possible at High Speeds
Bioengineers from UCLA and University of Tokyo have significantly increased the speed at which large liquid droplets, potentially containing individual live cells, can be sorted intact and in bulk.May 29, 2020 | Large Droplet-Sorting Now Possible at High Speeds ...
May 22, 2020 | Deep learning-based screening of sickle cell disease using a mobile microscope
The strong need for improved access to testing led us to develop an automated method to diagnose SCD using images of a blood smear captured using a cost-effective mobile microscope.May 22, 2020 | Deep learning-based screening of sickle cell disease using a mobile...
May 4, 2020 | Myst Therapeutics Appoints George Smith as Vice President of Business Operations
Myst Therapeutics (Myst), a preclinical stage biotechnology company focused on developing selected TIL-based autologous T cell (PuriT™) therapy products for cancer, announced the appointment of George Smith, PhD, MBA as Vice President of Business Operations.May...